Singleron announced their participation in the upcoming 64th ASH Annual Meeting & Exposition 14.11.20222’Singleron to present novel single cell sequencing solutions for blood cancer research at the 64th American Society of Hematology (ASH) Annual Meeting & ExpositionCOLOGNE, Germany, November 14, 2022 – Singleron Biotechnologies GmbH, a pioneer in development and commercialization of innovative single cell sequencing analysis solutions for precision medicine, announced today their participation in the upcoming 64th American Society of Hematology (ASH) Annual Meeting & Exposition in New Orleans, LA (December 10-13, 2022).At the ASH 2022 company booth (#3351), Singleron will be showcasing their latest multi-omics single cell sequencing solutions, from kits and instruments to their bioinformatic database pipeline tailored for blood cancer research. Singleron’s unique technologies can advance translational research to deepen the understanding of heterogenous cell populations in healthy and diseased tissues, promoting the development of future treatment strategies to target hematological disorders.Singleron will be featured in three poster presentations, including an awarded abstract by Nora Grieb and colleagues (Leipzig, Germany), who compared circulating tumor cells with non-malignant cells by applying single cell multi-omics technologies. Their peripheral blood screening approach illustrates how single cell sequencing data might be used in the future to apply targeted treatment strategies in plasma cell leukemia and multiple myeloma patients.More information on accepted abstracts and poster presentations featuring Singleron can be found in the table below.About Singleron Founded in 2018, Singleron develops and commercializes single cell multi-omics products that can be used in both research and clinical settings. Its current product portfolio includes instruments, microfluidic devices, reagents, software analysis and database solutions that facilitate high-throughput single cell analysis. The company currently has offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in over 2000 laboratories in hospitals, research institutes, and pharmaceutical companies.Media contact Email: info@singleronbio.comCheck out our latest news and events Learn more 24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more 24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more 24.10.08 Singleron and Bioscreen Announce Strategic Partnership to Enhance Access to Single Cell Multi-Omics Solutions for India Researchers Cologne, October 8, 2024 – Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor… Read more
24.11.20 Singleron Partners with TOMY to Expand Single Cell Offerings in Japan Cologne, November 20, 2024 – Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co.,… Read more
24.10.28 B2B-RARE: Bench to Bedside – Rapid Diagnosis and Personalized Treatment of Rare Neuromuscular Diseases For the German version of the article, see here. NRW, 28th October 2024 – More than 400 genetically determined neuromuscular diseases (NME) are rare diseases…. Read more
24.10.08 Singleron and Bioscreen Announce Strategic Partnership to Enhance Access to Single Cell Multi-Omics Solutions for India Researchers Cologne, October 8, 2024 – Singleron Biotechnologies, a leading innovator in single cell multi-omics solutions, has announced a strategic partnership with Bioscreen, a renowned distributor… Read more